Answers are grounded in this paper and cite their sources.
Given the recent research linking adherence to lung health outcomes, there is a growing need to measure and evaluate adherence in clinical care. As new medications are approved for CF, methods to monitor adherence also need to be developed and approved. Clinicians need to continue to assess barriers to adherence to be able to individually tailor interventions to a patient's needs.
No takes yet. Share an insight, caveat, or question.
Eakin et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: